Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing precisely lidocaine hydrochloride 200 milligram/20 milliliter conventional release solution for injection ampule |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 100 milligram/10 milliliter conventional release solution for injection syringe |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 100 milligram/10 milliliter conventional release solution for injection syringe |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 20 milligram/2 milliliter and methylprednisolone acetate 80 milligram/2 milliliter conventional release suspension for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Lidocaine hydrochloride 5 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 5 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 35 mg/g eye gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 35 mg/g eye gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 20 mg/g cutaneous gel |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 20 mg/g cutaneous gel |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 30 milligram/1 milliliter conventional release cutaneous cream (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 25 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 25 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 2 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 2 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 6 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 40 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 40 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 50 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 50 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone acetate 2.75 mg/g and lidocaine hydrochloride 50 mg/g cutaneous ointment |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 1 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Adrenaline 10 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine 10 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine 2 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine (as epinephrine bitartrate) 5 microgram/1 milliliter and lidocaine hydrochloride 5 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 40 mg/mL oropharyngeal solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 40 milligram/1 milliliter conventional release cutaneous solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 20 mg/mL oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 20 mg/mL oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Adrenaline 1 microgram/mg and lidocaine hydrochloride 100 microgram/mg cutaneous patch |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Lidocaine hydrochloride 50 mg/mL and phenylephrine hydrochloride 5 mg/mL cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 50 mg/mL and phenylephrine hydrochloride 5 mg/mL cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Hydrocortisone 2 mg/g and lidocaine hydrochloride 10 mg/g cutaneous spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Domiphen bromide 500 microgram and lidocaine hydrochloride 5 mg oromucosal lozenge |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely cetylpyridinium chloride 1 milligram/1 gram and lidocaine hydrochloride 3.3 milligram/1 gram conventional release dental gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 10 milligram/1 milliliter and methylprednisolone acetate 40 milligram/1 milliliter conventional release suspension for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
3 |
Lidocaine hydrochloride 40 mg/g and metronidazole 10 mg/g and sucralfate 70 mg/g cutaneous cream |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
3 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Adrenaline (as adrenaline acid tartrate) 5 microgram/mL and lidocaine hydrochloride 10 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely benzoxonium chloride 1 milligram and lidocaine hydrochloride 1 milligram/1 each conventional release chewable tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely benzoxonium chloride 1 milligram and lidocaine hydrochloride 1 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely glucose 75 milligram/1 milliliter and lidocaine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely glucose 75 milligram/1 milliliter and lidocaine hydrochloride 50 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely epinephrine (as epinephrine bitartrate) 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely epinephrine (as epinephrine bitartrate) 12.5 microgram/1 milliliter and lidocaine hydrochloride 20 milligram/1 milliliter conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Lidocaine hydrochloride monohydrate (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Lidocaine hydrochloride anhydrous (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
|
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely lidocaine hydrochloride 20 milligram/1 milliliter conventional release oromucosal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely cetylpyridinium chloride 200 microgram/1 gram and chlorocresol 1 milligram/1 gram and lidocaine hydrochloride 9 milligram/1 gram conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
3 |
Product containing precisely cetylpyridinium chloride 200 microgram/1 gram and chlorocresol 1 milligram/1 gram and lidocaine hydrochloride 9 milligram/1 gram conventional release oromucosal solution (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
3 |
Chlorhexidine gluconate 2 mg/mL and lidocaine hydrochloride 500 microgram/mL oromucosal spray |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Chlorhexidine gluconate 2 mg/mL and lidocaine hydrochloride 500 microgram/mL oromucosal spray |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely lidocaine hydrochloride anhydrous (as lidocaine hydrochloride) 50 milligram/1 milliliter and naphazoline nitrate 200 microgram/1 milliliter conventional release oromucosal solution (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
1 |
Product containing precisely aminoacridine hydrochloride 500 microgram/1 gram and lidocaine hydrochloride 6.6 milligram/1 gram conventional release oromucosal gel (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |
Product containing precisely aminoacridine hydrochloride 500 microgram/1 gram and lidocaine hydrochloride 6.6 milligram/1 gram conventional release oromucosal gel (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Lidocaine hydrochloride |
Inferred relationship |
Some |
2 |